Top Page
HitIQ Limited
(Sydney:HIQ)
HitIQ Limited (HIQ) vs. iShares MSCI Australia ETF (EWA)
HitIQ Limited Business Overview & Revenue Model
HitIQ Limited Financial Statement Overview
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.23M | 2.01M | 4.75M | 774.26K | 619.02K | 406.68K |
| Gross Profit | -956.20K | -2.18M | 334.63K | 242.73K | 243.43K | -3.28M |
| EBITDA | -6.60M | -5.99M | -2.54M | -4.31M | -6.54M | -4.79M |
| Net Income | -7.02M | -7.21M | -3.20M | -5.04M | -6.95M | -5.06M |
Balance Sheet | ||||||
| Total Assets | 1.46M | 3.28M | 3.73M | 3.13M | 4.55M | 9.49M |
| Cash, Cash Equivalents and Short-Term Investments | 359.17K | 990.96K | 584.02K | 1.98M | 2.94M | 8.96M |
| Total Debt | 1.53M | 5.66M | 3.20M | 1.69M | 2.16M | 709.34K |
| Total Liabilities | 6.64M | 7.30M | 5.20M | 3.18M | 3.38M | 1.56M |
| Stockholders Equity | -5.18M | -4.02M | -1.47M | -46.86K | 1.17M | 7.92M |
Cash Flow | ||||||
| Free Cash Flow | -5.02M | -4.68M | -4.12M | -4.57M | -6.57M | -2.18M |
| Operating Cash Flow | -5.01M | -4.65M | -4.10M | -4.51M | -6.51M | -2.13M |
| Investing Cash Flow | -7.20K | -28.57K | -20.78K | -54.73K | -918.06K | -54.84K |
| Financing Cash Flow | 4.71M | 5.09M | 2.73M | 3.61M | 1.41M | 10.71M |
HitIQ Limited Technical Analysis
HitIQ Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | AU$35.49M | -4.21 | -52.26% | ― | -36.68% | 79.41% | |
47 Neutral | AU$18.61M | 3.95 | 7.57% | ― | 28.91% | -1050.00% | |
44 Neutral | AU$9.49M | -0.96 | 152.58% | ― | -40.05% | -49.57% | |
44 Neutral | AU$10.57M | -2.48 | -578.72% | ― | 241.34% | 44.19% | |
43 Neutral | AU$72.61M | -6.64 | -59.96% | ― | ― | ― | |
42 Neutral | AU$3.94M | -1.98 | 20.02% | ― | -9.90% | 34.07% |
HitIQ Limited Corporate Events
HITIQ Limited has updated its registered office address to new premises in South Melbourne, Victoria, effective immediately, as required under ASX listing rules. The administrative change is not expected to alter the company’s operations but ensures investors and stakeholders have up-to-date corporate contact details as HITIQ continues to advance its concussion management and athlete safety technologies.
Through its PROTEQT platform and instrumented mouthguards, co-developed with Shock Doctor, HITIQ aims to strengthen its position in the growing market for data-driven head impact monitoring in sports. The reaffirmation of its focus on real-time concussion management solutions underscores the company’s strategy to support safer participation in sport and enhance its appeal to teams, clinicians, and researchers seeking robust athlete welfare tools.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has requested an immediate extension to the voluntary suspension of its HIQOA listed options on the Australian Securities Exchange. The company has made this move in connection with an issue under specific sections of the Corporations Act related to the quoted options issued on 22 December 2025.
The suspension is intended to help HitIQ manage its continuous disclosure obligations while it prepares a market announcement on the matter. HitIQ expects to release this announcement before normal trading begins on 24 March 2026, and the suspension will lift either at that time or once the disclosure is made, with the company stating it knows of no reason the suspension should not be granted.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HITIQ Limited has reported a change in director Matthew Clayworth’s interests, following the issue of securities in lieu of director’s fees. Clayworth received 477,273 fully paid ordinary shares and an equal number of performance rights at a deemed issue price of $0.022, increasing his direct holding while his indirect holdings through investment and superannuation entities remained unchanged.
The securities were issued as part of a fee arrangement approved at an extraordinary general meeting on 6 February 2026, reflecting the company’s continued use of equity-based compensation for governance stakeholders. The adjustment modestly increases director alignment with shareholders by tying a larger portion of Clayworth’s remuneration to HITIQ’s future share performance and capital management outcomes.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has requested an immediate extension to the voluntary suspension of its HIQOA listed options on the ASX, citing issues related to the Corporations Act provisions governing the December 2025 issue of those options. The suspension is intended to help the company manage its continuous disclosure obligations while it prepares a market announcement addressing the matter.
The company has asked that trading in the HIQOA options remain suspended until the earlier of normal trading on 17 March 2026 or the release of its forthcoming announcement, which it expects to lodge before that date. HitIQ stated it is unaware of any reason the suspension should not be granted, signalling a focused effort to resolve compliance questions around the option issue while maintaining regulatory transparency for investors.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has issued 2,511,994 fully paid ordinary shares on 6 March 2026 and has confirmed that this issuance was conducted without a prospectus or product disclosure statement under the exemption provisions of the Corporations Act. The company states it is in compliance with its financial reporting and continuous disclosure obligations and that there is currently no excluded information that would need to be disclosed to the market, signalling that the share issue is being carried out within the existing regulatory framework.
The notice serves primarily to preserve the ability for the new shares to be traded without further disclosure, reinforcing transparency around the capital raising process for existing and potential investors. While the announcement does not detail the purpose or terms of the share issue, it underscores HitIQ’s intent to adhere to statutory disclosure standards, which is relevant for shareholders assessing regulatory risk and governance practices.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has notified the ASX of the issue of 1,431,819 unquoted performance rights, recorded under the code HIQAU, with an issue date of March 6, 2026. The move reflects the company’s ongoing use of equity-based instruments, likely for incentives or compensation, and marginally increases its pool of potential future ordinary shares, which may impact existing shareholders through future dilution.
The transaction involves only unquoted performance rights, meaning they do not immediately trade on-market and will typically vest subject to performance or service conditions. This type of issuance is standard capital management practice for listed companies and signals HitIQ’s continued reliance on long-term, equity-linked incentives to align staff and executive interests with shareholder value.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has applied to the ASX for quotation of 1,830,176 new ordinary fully paid shares, to be traded under its existing ticker HIQ. The shares were issued on 6 March 2026 as non-cash remuneration in lieu of directors’ fees, following shareholder approval at an extraordinary general meeting held on 6 February 2026.
The move effectively conserves cash while compensating the board in equity, modestly increasing the company’s share count and aligning directors’ interests more closely with shareholders. The additional quoted securities may slightly dilute existing holdings but reflect continued use of share-based payments as a capital management tool within the company’s governance framework.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has applied to the ASX for quotation of 681,818 new ordinary fully paid shares and 340,909 options expiring on 30 December 2028, with an issue date of 6 March 2026. The move reflects an expansion of the company’s listed capital base, potentially enhancing liquidity in its securities and providing additional instruments for investors as part of previously announced capital management transactions.
These newly quoted securities stem from transactions already disclosed to the market, indicating a follow-through on earlier capital-raising or incentive arrangements. For stakeholders, the additional shares and long-dated options may dilute existing holdings but could also support HitIQ’s ability to fund operations and strategic initiatives through broader access to equity capital.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has disclosed a change in the shareholding of director Earl Eddings, who increased his direct and indirect holdings through on-market purchases. Eddings acquired a total of 500,000 fully paid ordinary shares at $0.015 per share, lifting both his personal stake and that of his E4 Family Super Fund, which may be interpreted by investors as a signal of confidence in the company’s prospects and alignment of board and shareholder interests.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ’s PROTEQT head impact protection product has expanded into a broad multi-channel retail network, now sold via rebel stores nationwide, Chemist Warehouse Marketplace, Amazon Marketplace Australia, and through an agreement with NARTA that opens access to major electronics and technology retailers. This distribution push complements the company’s existing direct-to-consumer channel and positions PROTEQT across multiple key consumer categories, from sporting goods to health and wellness.
To support the rollout, HitIQ has launched a national marketing campaign with Sports Entertainment Network, delivering more than 1,000 radio advertisements integrated into premium AFL and NRL broadcasts across major Australian cities during peak equipment purchasing months. Early sales momentum is building across national sporting organisations, retail and club channels, and the company has secured its first international rugby club order from Scotland’s Kinross Rugby Club, signalling initial traction in established overseas rugby markets and a platform for further international expansion.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has disclosed a substantial change in director Matthew Clayworth’s interests following the conversion of convertible notes into equity. Through Harmil Angel Investments Pty Ltd, where he is the nominated board representative, Clayworth’s indirect holding in HitIQ increased by 97,474,962 fully paid ordinary shares at a deemed price of $0.02 per share.
Post-transaction, Harmil Angel Investments now holds 161,128,604 fully paid ordinary shares in the company, while Clayworth’s direct and superannuation-related holdings remain unchanged. The conversion, approved at an extraordinary general meeting on 6 February 2026, signals a significant strengthening of equity held by a key insider, potentially aligning director and shareholder interests more closely as the company executes its strategic plans.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has requested an immediate extension to the voluntary suspension of trading in its HIQOA listed options on the ASX, citing issues related to the issuance of those options on 22 December 2025 under specific sections of the Corporations Act. The company says the suspension is needed to manage its continuous disclosure obligations and will remain in place until either an announcement on the matter is released or normal trading resumes on 10 March 2026, with the board indicating it expects to update the market before that date.
The request, approved by HitIQ’s chair, signals the company is actively addressing a regulatory matter linked to its previously issued quoted options, and is seeking to ensure the market is fully informed before trading in those options resumes. While ordinary share trading is not mentioned as affected, the move temporarily restricts liquidity in the HIQOA options series and highlights ongoing compliance scrutiny around secondary capital instruments on the ASX.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HITIQ Limited has issued 1,780,000 fully paid ordinary shares on 27 February 2026 without a prospectus, relying on provisions of the Corporations Act that allow such an issue to be made without formal disclosure to investors. The company states it remains compliant with its financial reporting and continuous disclosure obligations and confirms there is no excluded information that would need to be disclosed to the market at this time.
The notice, lodged under section 708A(5)(e) of the Corporations Act, effectively clears these newly issued shares for potential secondary trading by confirming regulatory compliance. This step maintains transparency for existing and prospective shareholders and signals that HITIQ sees no undisclosed price-sensitive information that could affect trading in its securities.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has notified the market of the issue of 5,660,000 unquoted performance rights under its employee incentive scheme, with an issue date of 27 February 2026. The new performance rights, which are not intended to be quoted on the ASX, form part of the company’s broader remuneration and retention strategy aimed at aligning employee interests with long-term shareholder value and supporting its ongoing growth objectives.
The issuance of these securities signals HitIQ’s continued reliance on equity-based incentives to attract and retain key talent in a competitive sports technology market. By expanding its pool of performance rights, the company is reinforcing its commitment to incentivising performance and execution of its strategic plans, which may lead to future dilution but is designed to support long-term operational and commercial outcomes.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has issued 97,474,962 fully paid ordinary shares, expanding its share capital base without a prospectus or other disclosure document under Part 6D.2 of the Corporations Act. The company has formally notified the market of this issuance under section 708A(5)(e), confirming that it is up to date with its financial reporting and continuous disclosure obligations and that there is no excluded information that would be material to investors.
The notice underscores that HitIQ remains compliant with key provisions of the Corporations Act applicable to disclosing entities, including Chapters 2M and sections 674 and 674A. By affirming there is no withheld price-sensitive information, the announcement aims to reassure shareholders and prospective investors about regulatory transparency around the new shares and their trading in the secondary market.
The most recent analyst rating on (AU:HIQ) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has applied for quotation on the ASX of 97,474,962 new ordinary fully paid shares, with an issue date of 25 February 2026. The move significantly increases the number of quoted securities on issue, indicating a notable capital-related event that may affect the company’s market liquidity, ownership structure and positioning with investors.
The application under the ASX Appendix 2A framework confirms the company’s compliance with listing requirements for the new shares. While the announcement does not detail the specific purpose of the new securities, the scale of the issuance suggests a material development in HitIQ’s capital management strategy that existing and prospective shareholders will monitor closely.
The most recent analyst rating on (AU:HIQ) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited reported a 3.2% decline in revenue to $997,178 for the half year ended 31 December 2025, while narrowing its after‑tax loss to $2,898,554, a 6.2% improvement from the prior corresponding period. The company did not declare any dividends and recorded negative net tangible assets of 0.98 cents per share, underscoring continued balance sheet pressure as it invests in its concussion management technology offering.
The modest reduction in losses suggests some progress in cost control or efficiency, but the combination of shrinking revenue and deep negative net tangible assets highlights ongoing challenges in achieving sustainable scale. With no dividend payments and continued losses, shareholders face a prolonged wait for returns as HitIQ pursues commercial traction in its specialised concussion technology niche.
The most recent analyst rating on (AU:HIQ) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has requested and received an immediate voluntary suspension of its HIQOA listed options from quotation on the ASX, with the suspension applying only to this specific class of securities and not to the company’s other quoted securities. The move is tied to an issue under sections 723(3) and 724(1)(b)(ii) of the Corporations Act relating to options issued on 22 December 2025, and is intended to help the company manage its continuous disclosure obligations while it prepares a market announcement expected before trading resumes, currently targeted for 3 March 2026.
The suspension isolates potential regulatory or disclosure concerns to the HIQOA options without disrupting trading in HitIQ’s main securities, limiting broader market impact while the company addresses the Corporations Act issue. Stakeholders in the affected options face a temporary halt in liquidity and price discovery, but the defined suspension window and the board-approved request signal an effort to provide clarity and regulatory compliance within a short timeframe.
The most recent analyst rating on (AU:HIQ) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HITIQ Limited has disclosed that it failed to lodge a required cleansing notice within the mandated five business days after issuing shares on 19 January 2026 due to an administrative oversight. The company’s review found that none of these shares had been offered or sold, and all recipients have agreed to voluntary escrow arrangements until either 12 months from issue or the release of a cleansing prospectus, limiting any immediate market impact.
Separately, HITIQ identified an issue with the timing of quotation for certain HIQOA options issued to GBA Capital and SP Corporate Advisory under a 2025 rights issue prospectus, which were admitted to quotation after the three-month statutory window. As a result, those advisor options are deemed void and HITIQ is obliged to return subscription funds unless a court extends the quotation period, prompting the company to seek court orders and request a voluntary suspension of HIQOA options while the matter is resolved, creating uncertainty for advisors and option holders.
The most recent analyst rating on (AU:HIQ) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has requested and been granted a trading halt on its securities by the ASX while it investigates a potential inadvertent failure to lodge required cleansing notices for recently issued shares and listed options. The halt, expected to last until an announcement is made or normal trading resumes on 24 February 2026, is intended to help the company manage its continuous disclosure obligations and minimise market uncertainty while it addresses the compliance issue.
ASX Compliance confirmed that HitIQ securities will remain in a trading halt until the pending announcement clarifies the situation regarding the alleged non-lodgement. The move underscores the regulatory sensitivity around capital raisings and disclosure in the small-cap technology sector, with investors likely to scrutinise the forthcoming update for any implications on past security issues and the company’s governance practices.
The most recent analyst rating on (AU:HIQ) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HITIQ Limited has appointed Mr Lachie Mallia and Ms Nova Taylor as joint company secretaries, replacing outgoing secretary Ms Michelle Sabatino. Mallia, a director at Bio101 Financial Advisory and an experienced CFO and company secretary in the healthcare sector, and Taylor, an ASX-experienced governance professional, will oversee the company’s compliance and communications with the ASX on Listing Rule matters, signalling a continued focus on strengthening corporate governance and regulatory oversight as the business advances its concussion technology strategy.
The most recent analyst rating on (AU:HIQ) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HITIQ Limited, a concussion management technology company listed on the ASX, held its General Meeting on 6 February 2026, at which shareholders considered a suite of capital and remuneration-related resolutions. The meeting, where two previously flagged resolutions were withdrawn, saw strong shareholder support via poll for the approval of share issues tied to the conversion of convertible notes, grants of general and specific security interests to lender No Bull Health Pty Ltd, ratification of prior placement securities, and approval of additional placement securities to director Tony Toohey. Investors also backed the issuance of options to the lead manager and multiple resolutions allowing directors to receive securities in lieu of fees, underscoring shareholder endorsement of HITIQ’s current funding structure and governance approach as it continues to execute its growth strategy in concussion technology and athlete safety markets.
The most recent analyst rating on (AU:HIQ) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has scheduled its 2026 General Meeting for 11:00am on Friday, 6 February 2026, with shareholders invited to attend under its ASX listing (ASX: HIQ). The meeting will cover formal business items including resolutions 1–10, noting that resolutions 5 and 10 have been withdrawn, followed by a poll on resolutions, an executive chair presentation, a general Q&A session, and refreshments, indicating a standard governance and investor engagement process without any disclosed strategic or operational changes at this stage.
The most recent analyst rating on (AU:HIQ) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HITIQ Limited has drawn down an additional $500,000 from its existing R&D Tax Incentive loan facility with No Bull Health Pty Ltd, lifting total borrowings under the arrangement to $1.23 million and providing early access to a further portion of its forecast 2026 R&D tax refund. The short-term funding, to be repaid upon receipt of the 2026 R&D Tax Incentive refund, underscores the company’s reliance on R&D-backed financing to support ongoing product development in concussion management technology, with potential implications for liquidity management and the pace of investment in its growth initiatives.
The most recent analyst rating on (AU:HIQ) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has signed an exclusive three-year national partnership with Hockey Australia, becoming the governing body’s Official Player Safety Partner and deploying its PROTEQT head-impact monitoring technology across the full hockey pathway, from grassroots to the Hockeyroos and Kookaburras. The agreement gives HitIQ prioritised access to more than 105,000 registered players, including roughly 92,000 aged 12 and over, and is expected to generate an estimated A$20–25 million in multi-year revenue through hardware sales and repeat device purchases, while establishing a scalable model for similar deals with other sports. By unifying player safety practices and capturing population-level data on head impacts, the partnership strengthens HitIQ’s position in the sports tech and player-welfare market and could influence broader national and international debates on brain health in sport.
The most recent analyst rating on (AU:HIQ) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has announced that director James Barrie ceased to be a director of the company on 30 January 2026, with the change formally notified to the ASX under listing rule requirements. Barrie retains a direct holding of 70,000 fully paid ordinary shares and an indirect interest through Festing Mill Pty Ltd
The most recent analyst rating on (AU:HIQ) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HITIQ Limited has announced the immediate resignation of Director and Company Secretary James Barrie, who stepped down after notifying the board of a potential future conflict of interest linked to another of his directorships. As a consequence, resolutions relating to Barrie have been withdrawn from the company’s upcoming extraordinary general meeting, and HITIQ has begun the process of recruiting a new Company Secretary. In the interim, existing Company Secretary Michelle Sabatino will continue in the role, oversee an orderly handover once a successor is appointed, and assume responsibility for all ASX Listing Rule communications, signalling a managed transition aimed at minimising disruption to the company’s governance and regulatory compliance.
The most recent analyst rating on (AU:HIQ) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ reported a pivotal December quarter as it accelerates from technology validation to commercial rollout of its PROTEQT concussion monitoring platform, securing an exclusive Canadian distribution deal that opens the North American collision-sports market and provides a pathway into the US. Domestically, the company began national retail distribution with Rebel, expanding access to community athletes and boosting brand visibility, while its selection in an Australian Research Council-funded brain injury program and new US collegiate research with Smith College Women’s Rugby further strengthen its evidence base and appeal to regulators and medical stakeholders. HitIQ also broadened its business model through a world-first partnership with insurer Sportscover to embed PROTEQT into sports insurance offerings, initially with Hockey Australia, and reinforced its balance sheet with an oversubscribed $925,000 capital raise and shareholder approval at its AGM, supporting ongoing product development and commercial execution.
The most recent analyst rating on (AU:HIQ) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has applied for quotation on the ASX of 2,772,728 new fully paid ordinary shares, to be traded under its existing ticker HIQ. The securities, issued on 19 January 2026 as part of previously announced transactions, will increase the company’s quoted share capital, potentially enhancing liquidity for investors and supporting HitIQ’s ongoing capital management initiatives.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has announced plans to issue up to 2,772,728 new fully paid ordinary shares via a placement. The proposed capital raising, to be completed on 19 January 2026, is intended to expand the company’s issued capital base and may support its ongoing operational or growth initiatives, with implications for existing shareholders through equity dilution and potential strengthening of the balance sheet.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HITIQ Limited has chosen to preserve cash by settling a $50,000 investor relations fee owed to Spark Plus Pte Ltd through the issuance of 2,272,728 ordinary shares at a deemed price of A$0.022 per share, aligned with its most recent capital raising. The company has also issued 500,000 shares to ambassador Nathan Murphy under his agreement, with all new shares to be issued from HITIQ’s existing ASX Listing Rule 7.1 placement capacity, a move that modestly dilutes existing shareholders while supporting ongoing operational and promotional activities without additional cash outlay.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has called a hybrid General Meeting of shareholders for 11:00am AEDT on Friday, 6 February 2026, allowing investors to participate either in person at the company’s South Melbourne office or online, where they can watch, ask questions and vote. In line with updated Corporations Act requirements, the company will not mail physical copies of the Notice of Meeting and Explanatory Statement, instead directing shareholders to access these documents via its share registry, ASX company page or website, and strongly encouraging proxy voting ahead of the meeting, reflecting an ongoing shift toward digital governance and shareholder engagement practices.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has called a general meeting of shareholders for 11:00am (AEDT) on Friday, 6 February 2026 in South Melbourne and online, and has outlined procedures for proxy appointment and voting ahead of the event. The proxy form details how investors can appoint the chair or another proxy, direct votes on a series of funding- and remuneration-related resolutions—including approval of share and option issues, ratification of prior placements, security arrangements with No Bull Health Pty Ltd, and issuance of securities to directors in lieu of fees—underscoring ongoing capital management and governance decisions that may affect shareholder dilution, director compensation structure and the company’s financing arrangements.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has called a hybrid general meeting for 6 February 2026 to seek shareholder approval for a series of capital and financing measures that could significantly alter its ownership and security structure. The key proposal is the potential issue of up to 470.2 million new shares on conversion of convertible notes held by the Harmil Group, which, together with existing holdings, could lift Harmil’s voting power from 12.80% to as much as 53.86%, effectively handing it majority control if approved. Shareholders are also being asked to approve general and specific security interests in favour of No Bull Health Pty Ltd, an associate of major shareholder Harmil Angel Investments, as well as to ratify a prior placement of 40.9 million shares and 20.45 million free-attaching options at $0.022. Independent expert reports have been provided to assess whether these related-party and control transactions are fair and reasonable for non-associated shareholders, underscoring the governance and control implications for existing investors.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has applied to the ASX for quotation of 6,181,818 options (ASX code HIQOA) expiring on 30 December 2028, with the securities issued as part of previously announced transactions. The move increases the number of listed options on issue and may provide additional liquidity and potential future capital for the company if the options are exercised, though no further operational or strategic details were disclosed in the filing.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
HitIQ Limited has applied to the ASX for quotation of 16,135,199 options (code HIQOA) expiring on 30 December 2028. The issuance, linked to previously announced transactions, increases the company’s listed option pool and may provide additional future capital if exercised, potentially affecting capital structure and dilution for existing shareholders.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.